(Q35544958)

8 August 2017

1 reference

title

Early intervention is key to successful management of Alzheimer disease (English)

1 reference

8 August 2017

Early Intervention Is Key to Successful Management of Alzheimer Disease (English)

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

15 March 2024

0 references

1

Steven DeKosky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14512815

15 March 2024

language of work or name

English

0 references

publication date

1 July 2003

1 reference

full work available at URL

8 August 2017

http://journals.lww.com/00002093-200307004-00004

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Alzheimer Disease and Associated Disorders

15 March 2024

published in

1 reference

8 August 2017

volume

17 Suppl 4

1 reference

8 August 2017

page(s)

S99-104

1 reference

Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study.

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

The incidence of dementia: a meta-analysis

15 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging.

15 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

15 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

15 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

15 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Drugs targeting Alzheimer's disease: some things old and some things new.

15 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Mild cognitive impairment in the elderly: predictors of dementia

15 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study

15 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Mild cognitive impairment: clinical characterization and outcome

15 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Classification criteria for mild cognitive impairment: a population-based validation study

15 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.

15 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Cognitive predictors of dementia in elderly community residents.

15 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Cognitive markers preceding Alzheimer's dementia in the healthy oldest old.

15 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

A prospective study of cognitive function and onset of dementia in cognitively healthy elders.

15 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study.

15 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study.

15 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Vascular basis of Alzheimer's pathogenesis

15 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Vascular disorder in Alzheimer's disease: role in pathogenesis of dementia and therapeutic targets

15 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Neuropathological stageing of Alzheimer-related changes

15 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease

15 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

15 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

MRI of entorhinal cortex in mild Alzheimer's disease

15 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease

15 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

15 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial

15 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging.

15 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease

15 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease

15 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

15 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

15 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Hippocampal formation glucose metabolism and volume losses in MCI and AD.

15 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

15 March 2024

35

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

15 March 2024

36

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Cholinergic markers in elderly patients with early signs of Alzheimer disease

15 March 2024

37

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease

15 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

15 March 2024

39

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study

15 March 2024

41

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Differential cholinergic regulation in Alzheimer's patients compared to controls following chronic blockade with scopolamine: a SPECT study.

15 March 2024

42

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group

15 March 2024

43

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease

15 March 2024

44

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Nerve inflammation halts trial for Alzheimer's drug.

15 March 2024

45

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

15 March 2024

46

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Vitamin E and Alzheimer disease: the basis for additional clinical trials

15 March 2024

47

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.

15 March 2024

48

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia

15 March 2024

49

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

15 March 2024

50

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

15 March 2024

51

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

15 March 2024

52

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

15 March 2024

54

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

15 March 2024

55

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

15 March 2024

56

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Postmenopausal estrogen replacement therapy and risk of AD: a population-based study.

15 March 2024

57

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Estrogen and cognitive functioning in men with mild cognitive impairment

15 March 2024

58

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine).

15 March 2024

59

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Memantine in moderate-to-severe Alzheimer's disease

15 March 2024

60

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

Memory enhancement: the search for mechanism-based drugs

15 March 2024

61

1 reference

https://api.crossref.org/works/10.1097/00002093-200307004-00004

15 March 2024

Identifiers

1 reference

8 August 2017

1 reference